#separator:Pipe
fb7df916-f7bc-4f56-836d-f50243e20121|\# General Psychiatry<br>\#\# Acute Behavioural Disturbance<br>\#\#\# Older People <!-- id:fb7df916-f7bc-4f56-836d-f50243e20121 -->|- Exclude delirium and BPSD: treat underlying cause<br>- Orals<br>&nbsp;&nbsp;  - Lorazepam 0.5-1mg PO q30mins (max 3mg)<br>&nbsp;&nbsp;  - Diazepam 2.5-5mg PO q30mins (max 30mg)<br>&nbsp;&nbsp;  - Preference for lorazepam over diazepam due to shorter action and less metabolites<br>&nbsp;&nbsp;  - Olanzapine 5-10mg (max 10mg)<br>&nbsp;&nbsp;  - Risperidone 0.5-1mg (max 2mg)<br>&nbsp;&nbsp;  - Preference for benzodiazepines as sedatives due to lower dosages required and safer adverse effects compared to antipsychotics<br>- IMs<br>&nbsp;&nbsp;  - Olanzapine 2.5mg IM (max 7.5mg)|general-psych sedation
0f6e6566-fcf3-4e2b-8998-4dfc52ead50a|\# General Psychiatry<br>\#\# Emergencies<br>\#\#\# Serotonin Syndrome<br>\#\#\#\# Assessment <!-- id:0f6e6566-fcf3-4e2b-8998-4dfc52ead50a -->|- Hx<br>&nbsp;&nbsp;  - Onset within 24 hrs following commencement or uptitration of serotonergic agent<br>- Hunter criteria requires serotinergic agent AND<br>&nbsp;&nbsp;  - Spontaneous clonus<br>&nbsp;&nbsp;  - (Inducible or ocular clonus) + ((agitation or diaphoresis) or (hypertonia + febrile))<br>&nbsp;&nbsp;  - Tremor + hyperreflexia|general-psych emergency serotonin-syndrome
46626e8a-1641-4d02-b736-5ff4ab206954|\# General Psychiatry<br>\#\# Emergencies<br>\#\#\# Serotonin Syndrome<br>\#\#\#\# Management <!-- id:46626e8a-1641-4d02-b736-5ff4ab206954 -->|- Medical emergency<br>- Escalation |general-psych emergency serotonin-syndrome
802ddc59-a9ed-4554-936a-bd0c14860692|\# General Psychiatry<br>\#\# Catatonia<br>\#\#\# Assessment <!-- id:802ddc59-a9ed-4554-936a-bd0c14860692 -->|- Bush-Francis Catatonia Rating Scale<br>&nbsp;&nbsp;  - Observe: excitement or stupor, mutism, staring, posturing, grimacing, stereotypy, mannerisms, verbigeration, withdrawal<br>&nbsp;&nbsp;  - Elicit: echopraxia/echolalia, rigidity, negativism, waxy flexibility, mitmachen, mitgehen, ambitendency<br>- Concerns: physical health complications (dehydration, VTE, pneumonia)|general-psych catatonia
135ed5e3-e1f7-456c-b420-371353cdf01c|\# General Psychiatry<br>\#\# Eating Disorders<br>\#\#\# Criteria for Inpatient Management <!-- id:135ed5e3-e1f7-456c-b420-371353cdf01c -->|- Vitals<br>&nbsp;&nbsp;  - Tachycardia + postural<br>&nbsp;&nbsp;  - SBP + postural drop<br>&nbsp;&nbsp;  - Temperature<br>&nbsp;&nbsp;  - BMI<br>- Bloods: FBC, LFT, EUC, CMP, glucose<br>&nbsp;&nbsp;  - Potassium<br>&nbsp;&nbsp;  - Sodium<br>&nbsp;&nbsp;  - Glucose<br>&nbsp;&nbsp;  - Phosphate<br>&nbsp;&nbsp;  - Magnesium<br>- ECG<br>- Psychiatric risks: suicidality, self-harm<br>- Failure of community management<br>```<br>- Vitals<br>- Ix: bloods, ECG<br>- Psychiatric risks<br>```|general-psych eating-disorders
b204577e-15f4-4383-b9ff-c6625ef9c3ae|\# Child and Adolescent Psychiatry<br>\#\# Tourette's Disease<br>\#\#\# Management <!-- id:b204577e-15f4-4383-b9ff-c6625ef9c3ae -->|- Pharmacotherapy<br>&nbsp;&nbsp;  - (1) Commence clonidine 50mcg once daily<br>&nbsp;&nbsp;  - (2) Trial aripiprazole, risperidone or haloperidol<br>- Psychosocial<br>&nbsp;&nbsp;  - Cognitive behavioural interventions for tics with **habit reversal training**<br>&nbsp;&nbsp;  - CBT with **exposure-response prevention**|child-psych tourettes
74e46e68-cfce-4f9b-91de-9007c490c971|\# Addiction Psychiatry<br>\#\# General Structure <!-- id:74e46e68-cfce-4f9b-91de-9007c490c971 -->|- Detoxification<br>- Rehabilitation<br>- Relapse prevention|addiction
d0ce1e09-b96e-4e93-84d7-fcf101c7187b|\# Addiction Psychiatry<br>\#\# Alcohol Use Disorder<br>\#\#\# Management of Alcohol Withdrawal <!-- id:d0ce1e09-b96e-4e93-84d7-fcf101c7187b -->|- Acute ie. withdrawal<br>&nbsp;&nbsp;  - Thiamine replacement<br>&nbsp;&nbsp;  - Commencement of alcohol withdrawal scale<br>&nbsp;&nbsp;  - Benzodiazepine management<br>&nbsp;&nbsp;&nbsp;&nbsp;    - Consider tapering from 10mg QID + PRN<br>&nbsp;&nbsp;  - Hydration|addiction alcohol-use-disorder
39f7d967-aa86-4ab3-84d2-687d6a9fc510|\# Addiction Psychiatry<br>\#\# Alcohol Use Disorder<br>\#\#\# Management of Alcohol Dependence <!-- id:39f7d967-aa86-4ab3-84d2-687d6a9fc510 -->|- Pharmacotherapy<br>&nbsp;&nbsp;  - Should be reviewed following a lapse, however continue for greater than 6 months if effective<br>&nbsp;&nbsp;  - Naltrexone<br>&nbsp;&nbsp;&nbsp;&nbsp;    - Dosing: commence three days after last drink, 25mg for two days, then 50mg daily<br>&nbsp;&nbsp;  - Acamprosate<br>&nbsp;&nbsp;&nbsp;&nbsp;    - Dosing: commence three days after last drink, 666mg TDS<br>&nbsp;&nbsp;  - Disulfiram<br>&nbsp;&nbsp;&nbsp;&nbsp;    - Dosing: commence 7 days after alcohol withdrawawl and 48 hrs after last drink, 200mg daily<br>&nbsp;&nbsp;  - Address psychiatric comorbidities eg. anxiety<br>&nbsp;&nbsp;  - Address physical complications<br>- Psychological<br>&nbsp;&nbsp;  - Motivational interviewing<br>&nbsp;&nbsp;  - CBT approaches<br>&nbsp;&nbsp;  - Relapse prevention strategies<br>- Social<br>&nbsp;&nbsp;  - Self-help programs eg. AA or Smart Recovery<br>&nbsp;&nbsp;  - Residential rehabilitation<br>&nbsp;&nbsp;&nbsp;&nbsp;    - 1-12 month programs requiring structured social supports<br>```<br>- Bio: naltrexone, acamprosate, disulfiram. Manage psychiatry comorbidity and physical complications.<br>- Psycho: motivational interviewing, CBT<br>- Social: self-help, residential rehab<br>```<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Quick Reference Guide to the Treatment of Alcohol Problems](https://www.health.gov.au/sites/default/files/quick-reference-guide-to-the-treatment-of-alcohol-problems.pdf)|addiction alcohol-use-disorder
